Over The Counter 10 July 2023: Prescription Slimming Drugs And Their OTC Alternatives, With OptiBiotix’s Stephen O’Hara
Executive Summary
In this episode, we explore recent consumer interest in prescription weight loss drugs such as Novo Nordisk's Wegovy with gut health expert Stephen O’Hara. As CEO of microbiome specialist OptiBiotix Health, O’Hara points to over-the-counter alternatives like prebiotic food supplements and medical devices, which may offer similar hunger-reducing benefits without the side effects associated with these drugs. By successfully negotiating health claim regulations, as well as investing in new markets and in new delivery formats like gummies, companies like Optibiotix are looking to take advantage of this new interest in slimming solutions, he explains.
Further Reading
Lilly And Novo Nordisk Shape Up For Obesity Treatment Battle Of The Heavyweights
ProBiotix Capitalizes On EU Monacolins Restriction With CholBiome Extension
UK’s OptiBiotix Offers GoFigure Prebiotic Range To Slim Down Saudi Arabia’s ‘Alarming’ Obesity Rates
UK’s OptiBiotix Launches Prebiotic Supplement Ingredient For European And African Markets
Wellbeing And Science Trends Will Drive Prebiotic And Probiotic Growth In 2021
UK Probiotics Distribution Deal Latest Milestone In OptiBiotix Growth Journey
Further Listening
Over The Counter 8 Aug 2022: The ‘Dos and Don’ts’ Of EU Supplement Innovation, With Mihai Inceu
Over The Counter 28 Feb 2022: The Future Of EU Probiotics Regulation, With David Pineda Ereño
These and all other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider.
Over The Counter Theme Music:
Warm Vacuum Tube by Admiral Bob (c)
Copyright 2019 Licensed under a Creative Commons Attribution (3.0) license